Restore Vision

Restore Vision Inc. is a clinical-stage biotechnology startup based in Tokyo, Japan.

Funding reportedLast round: Series A

ResearchMinato, Japan

About Restore Vision

Restore Vision Inc. is a clinical-stage biotechnology startup based in Tokyo, Japan.

Founded in November 2016, the company is dedicated to developing gene therapies aimed at restoring vision for individuals affected by blindness and inherited retinal disorders. The company specializes in regenerative medicine and optogenetics-based gene therapy. Its primary focus is on research and development of therapeutic candidates for retinal diseases. One of its key programs is RV-001, a GPCR-based optogenetic gene therapy, which has entered first-in-human clinical trials in Japan. Restore Vision is committed to advancing effective treatments for patients who have lost photoreceptor function.

What company datasets say Restore Vision raised

Funding, as reported

Reported in all2.5Bin the source's currency

Rounds4

Last roundSeries A

Last round size14.4M

Last round dateDec 2023

Investors listed13

On 5 portfolio pages

Investors who name them

Each firm lists Restore Vision on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

biotechnology researchophthalmologygene therapyaavb2bretinitis pigmentosa

Built with from their website

Sakura InternetGoogle WorkspaceGoogle MeetAmazon AWSGoogle Search ConsoleGmail

Sector: Research
Industry code: NAICS 541714, 325414
Region: Tokyo
Full record: Every detail in the company directory

Research in Japan

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Restore Vision in front of investors. Or tell us what we have wrong.

List your startup Send a correction